Najit Technologies, Inc.

Beaverton, OR

UEI
MHB6EFN66MD9
CAGE
3XTT4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
15232 NW Greenbrier Pkwy, Beaverton, OR 97006, USA
Website
najittech.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Consumer Discretionary
  2. Diversified Consumer Services
  3. Education Services
  4. Education
SIC code
82 Educational Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
Duke University THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA… 75N93019C00050 $384,430

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Oregon Health & Science University Support for National Primate Research Center P51OD011092 $35,000

Similar vendors

About the company

Najit Technologies, Inc. is a corporate entity registered to do business as Najit Technologies Inc. According to its website, Najit Technologies is dedicated to developing safe and effective vaccines against infectious diseases.

Through past prime federal contract awards, Najit Technologies has provided research and development services related to influenza vaccine optimization. This includes a subcontract from Duke University to utilize Najit's HydroVax vaccine platform to develop improved flu vaccines.

Through past prime and sub federal grants, Najit Technologies has conducted research and development of vaccine candidates against influenza, chikungunya, yellow fever, Zika and dengue viruses. This includes prime awards from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to support clinical trials of Najit's HydroVax inactivated chikungunya and yellow fever vaccine candidates. It also includes subawards from Oregon Health & Science University to develop a Zika virus vaccine candidate. Additionally, Najit has received a subaward from Oregon Health & Science University to provide optimization, production, testing and stability services in support of a dengue virus vaccine development project.

Quick answers

Is Najit Technologies, Inc. registered in SAM.gov?

Yes. Najit Technologies, Inc.'s SAM.gov registration is active through March 10, 2027.

What is Najit Technologies, Inc.'s most recent federal award?

Najit Technologies, Inc.'s most recent federal grant award is Development of an improved intranasal vaccine against influenza - despite the development of several types of influenza… (R41AI167146), from National Institute of Allergy and Infectious Diseases (NIH), on August 1, 2022.

On GovTribe

See Najit Technologies, Inc.'s full federal record

  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors